Article
Placental treatment with <i>insulin-like growth factor 1</i> via nanoparticle differentially impacts vascular remodeling factors in guinea pig sub-placenta/decidua
2022-09-27
Abstract excerpt
Clinically, fetal growth restriction (FGR) is only detectable in later gestation, despite pathophysiological establishment likely earlier in pregnancy. Additionally, there are no effective in utero treatment options for FGR. We have developed a nanoparticle to deliver human insulin-like 1 growth factor ( hIGF-1 ) in a trophoblast-specific manner which results in increased expression of hIGF-1 . IGF-1 signaling...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8c90ed78-b781-513e-acf1-2c16d9f7d51d
- DOI
- 10.1101/2022.09.26.509492
